Cotellic is indicated for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with vemurafenib. Active ingredients in BLINCYTO are:blinatumomab. Inactive ingredients in BLINCYTO are:citric acid monohydrate, lysine hydrochloride, polysorbate 80, trehalose dehydrate, sodium hydroxide and water for injection. Cobimetinib was approved by: FDA (USA) on November 10, 201, EMA (EU) on November 20, 2015 and TGA (AUS) on April 5, 2016

Where can I buy Cotellic Tablets?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. with over 20 years of domain experience.

The order for Cotellic (cobimetinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

For Cotellic or cobimetinib tablets price in India. Please call at M: +91 9811747774 or Email us at neeraj@indianpharmanetwork.co.in to know more details about the medicine and its cost price in India.
Cotellic (cobimetinib) tablets

Get In Touch

Facilitator under Patient Assistance Programs In India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Cotellic (cobimetinib) on prescription and Import License in Patient's Name only.

For overseas patients, Cotellic (cobimetinib) Tablets can be made available in Send your enquiry to find Cotellic (cobimetinib) Tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.